Top news from MedWatch this week
Monday
Closed for easter
Tuesday
Leo Pharma absorbs scrapped innovation hubs to streamline focus
Genmab ponders next steps after preliminary cancer candidate results
Bavarian Nordic to start phase III with Covid-19 booster in June
Ambu launches new gastroscope in Japan and Europe
Janssen’s sales of Darzalex exceed expectations
Wednesday
Cancer drug hope raises Genmab’s spirits after legal defeat
Demant lost ground at Veterans Affairs in March
Leo Pharma brings hair loss cream into phase II
Bavarian begins phase III trial of RSV vaccine in older adults
Thursday
Novo Nordisk initiates phase I trial of oral device
Sonion accuses Huawei and Sony of copying technology
Leo Pharma’s climate targets receive science-based stamp of approval
Friday
Qufora expects French approval in 2022, trains sights on million-dollar business
Astellas Pharma ends development of dust mite allergy vaccine
Danish Medicines Council makes five recommendations after April meeting
